MYOCARDIAL CONTRACTILE FUNCTION AND CEREBRAL BLOOD FLOW INDICES DYNAMICS IN HYPERTENSIVE OVERWEIGHT PATIENTS AFTER THERAPY BY ANTIHYPERTENSIVES COMBINED WITH STATINS

Authors

  • N. I. Petrik Zaporizhzhia Medical Academy of Postgraduate Education
  • I. M. Fushtei Zaporizhzhia Medical Academy of Postgraduate Education
  • G. J. Solonunka Zaporizhzhia Medical Academy of Postgraduate Education

DOI:

https://doi.org/10.11603/1811-2471.2020.v.i1.10937

Keywords:

systolic function, diastolic function, linear blood flow velocities, arterial hypertension, overweight patients

Abstract

The aim of the work was to assess the dynamics of systolic, diastolic function and remodeling of the left ventricle of the myocardium, linear blood flow velocities in the basins of the common carotid artery, internal carotid artery, external carotid artery, middle cerebral artery, vertebral artery (V2) in male and female patients with hypertension II stage and overweight under the influence of combination therapy with antihypertensive drugs and rosuvastatin.

Material and Methods. In 64 patients, the average age is 59.0 [48.0; 63.0] years, with stage II hypertension and overweight, the dynamics of systolic, diastolic function and remodeling of the left ventricle, linear blood flow velocities in the basins of the common carotid artery, internal carotid artery, external carotid artery, middle cerebral artery, vertebral artery under the influence of combination therapy were evaluated (fixed combinations of antihypertensive drugs – the equator (amlodipine 5 mg and lisinopril 10 mg) and valodip (amlodipine 5 mg and valsartan 80 mg) for 120 days), which includes rosuvastatin 10 mg per day.

Results. All patients underwent a general clinical, laboratory and instrumental examination in order to verify the diagnosis, identify complications and associated pathology. During treatment, an improvement in left ventricular contractility, its reverse remodeling, and an increase in systolic ejection power are observed. Indicators of diastolic function of the left ventricle after treatment indicate an improvement in the processes of relaxation of the left ventricle, its compliance and contractility of the left atrium during therapy, a decrease in left ventricular hypertrophy and a decrease in the risk of cardiovascular complications. A significant decrease in the diameters of the examined cerebral arteries (CommonAAA, ICA, ExternalCMA and PAA) against the background of the antihypertensive and antilipidemic therapy indicates an inverse structural and functional remodeling of the cerebral vessels – a decrease in thickness and increased elasticity of the vascular wall.

Conclusions. The improvement in the elastic properties of SMA as a result of the therapy indicates a significant reduction in cardiovascular risk, in particular, the risk of stroke. Thus, there is an improvement in cerebral circulation and cerebral trophism, which indicates the adequacy and feasibility of selected regular antihypertensive and anti-lipidemic therapy.

References

Stepurko, T., Semyhina, T., Barska, Yu., & Tymoshevska, V. (2019). Povedinkovi determinanty zdorovia (rezultaty natsionalnoho reprezentatyvnoho doslidzhennia “Indeks zdorovia. Ukraina”) [Behavioral determinants of health (results of the national representative survey “health index. Ukraine”)]. Visnyk APSVT – ATSVT Bulletin, 1, 102-124 [in Ukrainian].

Chumakova, G.A., Kuznetsova, T.Yu., Druzhilov, M.A., & Veselovskaya, N.G. (2018). Vistseralnoye ozhireniye kak globalnyy faktor serdechno-sosudistogo riska [Visceral obesity as a global factor in cardiovascular risk]. Rossiyskiy kardiologicheskiy zhurnal – Russian Journal of Cardiology, 23 (5), 7-14. DOI: http://doi.org/10.15829/1560-4071-2018-5-7-14. DOI: https://doi.org/10.15829/1560-4071-2018-5-7-14

Lee, J.J., Pedley, A., Hoffmann, U., Massaro, J. M., & Fox, C.S. (2016). Association of changes in abdominal fat quantity and quality with incident cardiovascular disease risk factors. J. Am. Coll. Cardiol., 68, 14, 1509-1521. DOI: https://doi.org/10.1016/j.jacc.2016.06.067. DOI: https://doi.org/10.1016/j.jacc.2016.06.067

Vecchié, A., Dallegri, F., Carbone, F., Bonaventura, A., Liberale, L., Portincasa, P., Frühbeck, G., & Montecucco, F. (2018). Obesity phenotypes and their paradoxical association with cardiovascular diseases. Eur. J. Intern. Med., 48, 6-17. DOI: https://doi.org/10.1016/j.ejim.2017.10.020. DOI: https://doi.org/10.1016/j.ejim.2017.10.020

Badimon, L., Bugiardini, R., Cenko, E., Cubedo, J., Dorobantu, M., Duncker, D.J., ..., & Koller, A. (2017). Position paper of the European Society of Cardiology-working group of coronary pathophysiology and microcirculation: obesity and heart disease. Eur. Heart J., 38, 1951-1958. DOI: https://doi.org/10.1093/eurheartj/ehx181. DOI: https://doi.org/10.1093/eurheartj/ehx181

Galyavich, A.S., Khairullin, R.N., Baleeva, L.V., Sluiter, P., Akimova, S.V., Galimzyanov, A.F., ..., & Terpstra, P. (2019). Faktory riska ishemicheskoy bolezni serdtsa u 27425 ambulatornykh patsiyentov [Risk factors of coronary artery disease in 27425 outpatients]. Rossiyskiy kardiologicheskiy zhurnal – Russian Journal of Cardiology, 66, 23-26 [in Russian]. DOI: http://doi.org/10.15829/1560-4071-2019-6-23-26. DOI: https://doi.org/10.15829/1560-4071-2019-6-23-26

Agasarov, L.G., Apkhanova, T.V., Kirgizova, O.Yu., & Frolkov, V.K. (2019). Mekhanizmy i printsipy korrektsii metabolicheskogo sindroma (obzor literatury) [Mechanisms and principles of metabolic syndrome correction (literature review)]. Vestnik novykh meditsinskikh tekhnologiy – Bulletin of New Medical Technologies, 3, 40-47. DOI: https://doi.org/10.24411/2075-4094-2019-16385 [in Russian].

Ott, A.V., & Chumakova, G.A. (2018). Epikardialnoye ozhireniye kak odin iz osnovnykh kriteriyev metabolicheski tuchnogo fenotipa ozhireniya i prediktorov subklinicheskogo ateroskleroza [Epicardial obesity as one of the basic criteria for metabolically unhealthy obesity phenotype and the predictor of subclinical atherosclerosis]. Kompleksnyye problemy serdechno-sosudistykh zabolevaniy – Complex Issues of Cardiovascular Diseases, 7 (1), 21-28. DOI: https://doi.org/10.17802/2306-1278-2018-7-1-21-28 [in Russian]. DOI: https://doi.org/10.17802/2306-1278-2018-7-1-21-28

Sevostyanova, Ye.V., Nikolayev, Yu.A., Mitrofanov, I.M., & Polyakov, V.Ya. (2019). Osobennosti polimorbidnosti u bolnykh arterialnoy gipertenziyey [Polymorbidity in hypertensive patients]. Arterialnaya gipertenziya – Arterial hypertension, 25 (2), 200-208. DOI: https://doi.org/10.18705/ 1607-419X-2019-25-2-200-208 [in Russian].

Jellinger, P.S., Handelsman, Y., Rosenblit, P.D., Bloomgarden, Z.T., Fonseca, V.A., Garber, A.J., ..., & Davidson, M. (2017). American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease. Endocrine Practice, 23, 2, 1-87. DOI: https://doi.org/10.4158/EP171764.APPGL. DOI: https://doi.org/10.4158/EP171764.APPGL

Spannella, F., Giulietti, F., Di Pentima, C., Ristori, L., Biondini, S., & Sarzani, R. (2019). “Double-trouble” atherogenic lipid profile in overweight/obese hypertensive patients phenotyped by 24-hour ambulatory blood pressure monitoring. Atherosklerosis, 287, e191. DOI: https://doi.org/10.1016/j.atherosclerosis.2019.06.579

van Dam, A.D., Boon, M.R., Berbée, J.F.P., Rensen, P.C.N., & van Harmelen, V. (2017). Targeting white, brown and perivascular adipose tissue in atherosclerosis development. European Journal of Pharmacology, 816, 82-92. DOI: https://doi.org/10.1016/j.ejphar.2017.03.051. DOI: https://doi.org/10.1016/j.ejphar.2017.03.051

Kireyev, T.R. (2018). Kompleksnaya otsenka sostoyaniya golovnogo mozga u patsiyentov s arterialnoy gipertoniyey pozhilogo vozrasta [Comprehensive assessment of the brain status in elderly patients with arterial hypertension]. Prakticheskaya meditsina – Practical Medicine, 16, 6, 225-227 [in Russian].

Mirzagaliyeva, N.Zh., Aringazina, R.A., Astrakhanov, A.R., & Otesin, M.A. (2019). Otsenka sostoyaniya sosudov u patsiyentov s arterialnoy gipertenziyey [Vascular condition assessment in patients with arterial hypertension]. Mezhdunarodnyy zhurnal serdtsa i sosudistykh zabolevaniy – International Heart and Vascular Disease Journal, 7, 21, 20-25 [in Russian].

Ostroumova, O.D., Ostroumova, T.M., Perepelov, V.A., & Velichko, M.V. (2017). Rol magnitno-rezonansnoy tomografii v vyyavlenii rannikh priznakov porazheniya golovnogo mozga pri arterialnoy gipertenzii [Role of magnetic resonance imaging in detecting early signs of brain damage in arterial hypertension]. Effektivnaya farmakoterapiya – Effective Pharmacotherapy, 33, 44-50 [in Russian].

Lindyna, M.L., & Shishkin, A.N. (2018). Sosudistyye narusheniya pri ozhirenii: faktory riska i klinicheskiye osobennosti [Vascular disorders in obesity: risk factors and clinical features]. Juvenis scientia. Medicine, 2, 9-13.

Golovina, A.Ye., Katamadze, N.O., Bondareva, Ye.B., Sayganov, S.A., & Bershteyn, L.L. (2017). Rol ultrazvukovoy vizualizatsii subklinicheskogo ateroskleroza sonnykh arteriy v prognozirovanii serdechno-sosudistogo riska v ramkakh pervichnoy kardiovaskulyarnoy profilaktiki [The role of ultrasound imaging of subclinical carotid atherosclerosis in predicting of cardiovascular risk in primary prevention of cardiovascular diseases]. Ateroskleroz i dislipidemii – Atherosclerosis and dyslipidemia, 1, 5-16 [in Russian].

Williams, B., Mancia, G., Spiering, W., Rosei, E.A., Azizi, M., Burnier, M., ..., & Desormais, I. (2018). ESC/ESH Guidelines for the management of arterial hypertension. Eur. Heart J., 39, 33, 3021-3104. DOI: https://doi.org/10.1093/eurheartj/ehy339. DOI: https://doi.org/10.1093/eurheartj/ehy339

Vlachopoulos, C., Xaplanteris, P., Aboyans, V., Brodmann, M., Cífková, R., Cosentino, F., ..., & Townsend, R.R. (2015). The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society. Atherosclerosis, 241, 2, 507-532. DOI: https://doi.org/10.1016/j.atherosclerosis.2015.05.007. DOI: https://doi.org/10.1016/j.atherosclerosis.2015.05.007

Hloba, M.V., Kalashnikov, V.Y., & Linska, H.V. (2017). Propozytsii shchodo standartyzatsii ultrazvukovoho doslidzhennia sudyn shyi ta holovy [Ultrasonography of blood vessels of the head and neck: proposals for standardization]. Ukrainskyi neirokhirurhichnyi zhurnal – Ukrainian Neurosurgical Journal, 1, 40-45 [in Ukrainian].

Atkov, O.Yu. (Ed.). (2015). Ultrazvukovoye issledovaniye serdtsa i sosudov [Ultrasound examination of the heart and blood vessels]. 2nd ed., suppl. and expanded. Moscow: Eksmo [in Russian].

Published

2020-05-05

How to Cite

Petrik, N. I., Fushtei, I. M., & Solonunka, G. J. (2020). MYOCARDIAL CONTRACTILE FUNCTION AND CEREBRAL BLOOD FLOW INDICES DYNAMICS IN HYPERTENSIVE OVERWEIGHT PATIENTS AFTER THERAPY BY ANTIHYPERTENSIVES COMBINED WITH STATINS. Achievements of Clinical and Experimental Medicine, (1), 143–155. https://doi.org/10.11603/1811-2471.2020.v.i1.10937

Issue

Section

Оригінальні дослідження